Recent Headlines
For Lentivirus Production: TransIT®-Lenti Transfection Reagent, Available from MoBiTec, Germany
TransIT®-Lenti Transfection Reagent, manufactured by Mirus Bio, US, is designed to enhance delivery of packaging and transfer vectors to adherent HEK 293T cell types and increase recombinant lentivirus production. - September 23, 2016 - MoBiTec GmbH
Batavia Biosciences Receives Grant to Develop New Vaccine Against Rotavirus
Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable rotavirus vaccine to the global health market. This vaccine aims to save many young children’s lives worldwide. - September 21, 2016 - Batavia Biosciences
We All Want to Live in a Yellow Submarine at Virun’s SupplySide West Booth
Go under the sea in a yellow submarine and cast your vote for the next Omega-3 Smoothie - September 15, 2016 - VIRUN
Recursion Pharmaceuticals Receives Fast-Track SBIR Grant to Study Age-Related Disease
Recursion Pharmaceuticals, an exciting biotech company located in the University of Utah’s Research Park, today announced a $223,000 Phase I Small Business Innovation Research award from the National Institutes of Health (NIH) via the National Institute on Aging (NIA). The award, which has... - September 15, 2016 - Recursion Pharmaceuticals
CHI's 8th Annual SCOPE: Summit for Clinical Ops Executives Returns to Miami, January 24-26, 2017
1,200+ Executives to gather for solutions on various aspects of clinical trial planning and management at 13 co-located conferences and 2 symposia - September 13, 2016 - Cambridge Healthtech Institute
CRISPR/Cas9 - Request a Free Sample for Your Genome Editing Research
The use of CRISPR/Cas9 has emerged as a powerful method for genome editing that can be delivered in multiple formats. MoBiTec together with Mirus Bio provide solutions to address delivery of Cas9 and guide RNA in plasmid, RNA, or RNP format. - September 10, 2016 - MoBiTec GmbH
Dextra UK Launched the World's Largest Commercial Glycan Array, Marketed in Germany and Other Countries Through Its Authorized Distributor MoBiTec GmbH
Dextra's Glycan Array Kit is a valuable tool for use in determining the glycan binding profile of proteins, eukaryotic cells, viruses, spores, bacteria, and parasites. It features 104 unique glycans carefully selected from cutting-edge libraries. - September 02, 2016 - MoBiTec GmbH
Silicone Suction Hose from AdvantaPure(R) is Now NSF Listed; Provides an Increased Level of Quality Assurance
AdvantaPure’s APSW silicone suction hose now boasts an NSF listing (NSF-51), giving users reassurance for the product’s compatibility with food, beverage and other clean applications. APSW is reinforced with a helical stainless steel wire and layers of fabric and silicone to handle both suction and discharge applications. The hose is available in smooth or convoluted O.D. styles, withstands temperatures up to 350 degrees F, and may be sterilized using several different methods. - September 02, 2016 - AdvantaPure
NuvOx Pharma Awarded NIH Grant to Develop Technology to Treat Endocarditis
NuvOx Pharma, a Tucson based biotechnology company, has been awarded a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health for $243,164.00 entitled, “Fibrin Targeted Microbubbles and Ultrasound for... - August 27, 2016 - NuvOx Therapeutics
PBTF Unites with We Can to Form California Chapter
The We Can Pediatric Brain Tumor Network is now the California Chapter of the Pediatric Brain Tumor Foundation. - August 25, 2016 - Pediatric Brain Tumor Foundation
FDA Allows NuvOx Pharma’s IND to Initiate Phase Ib Clinical Trial in Stroke
Evan Unger, MD, President and CEO of NuvOx, announced that the FDA has allowed an investigational new drug application (IND) for NVX-208 (dodecafluoropentane emulsion) to be tested in a Phase Ib trial in stroke patients. The trial will be performed at the University of Arkansas Medical System in... - August 22, 2016 - NuvOx Therapeutics
MiTeGen Awarded 2016 Inc. 5000 Recognition
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, has been awarded a listing on the 2016 Inc. 5000. The Inc.5000 recognizes the country's top 5000 fastest-growing private companies. - August 18, 2016 - MiTeGen, LLC
KinderPharm to Celebrate Grand Opening of New Exton Office
Pennsylvania Elected Officials to Participate in Ribbon-Cutting Ceremony and Grand Opening Event; KinderPharm is pleased to announce that it will hold a Grand Opening event and Ribbon-Cutting ceremony for its new office at 100 Arrandale Blvd., Exton, Pennsylvania on Friday, August 26th from 1 p.m. to 3 p.m. The event will feature a ribbon-cutting ceremony at 1 p.m., food and refreshments, and industry networking. - August 16, 2016 - KinderPharm LLC
Titanium Healthcare, Inc. Provides Update Regarding Current Ventures
Titanium Healthcare, Inc. (OTCQB: TIHC) ("Titanium") today announced the following updates: Odin Titanium previously announced the formation of Odin Applied Research Laboratories (“OARL”) to conduct a joint venture with Odin Industries, LLC. On September 11, 2015. The closing... - August 01, 2016 - Titanium Healthcare, Inc
Titanium Healthcare, Inc. Provides Update Regarding Annual 10K Report
Titanium Healthcare, Inc. (OTCQB: TIHC) ("Titanium") today announced that the continued delay in the filing of the Company's annual report on Form 10-K, which was due on April 15, 2016, is due to the challenges surrounding the following, which management has been addressing: -Recent... - July 31, 2016 - Titanium Healthcare, Inc
Fluorescent Cell Organelle Stains - Free Brochure Launched by MoBiTec GmbH
Fluorescent molecules and conjugates are invaluable tools in modern medical and biological laboratories. Cell-permeant fluorophores help reveal the localization of intracellular organelles and structures in live cells with minimal impairment. - July 30, 2016 - MoBiTec GmbH
Braincure Biotech Study Indicates New Target for Combating Alzheimer’s
A team of researchers led by Sírnir Thorsson has established that the protein GPR3 could be instrumental in relieving cognitive deficits and mitigating the production of "amyloid plaques." - July 21, 2016 - BrainCure Biotech
Braincure Biotech Publishes Two New Reports
With more than 90 medicines in clinical trials or awaiting approval and knowledge of Alzheimer’s increasing, patients and caretakers look towards the future with high spirits. - July 21, 2016 - BrainCure Biotech
MiTeGen Announces NANUQ™, an Automated High-Speed Cryocooling Device
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced the launch of their NANUQ™ automated, high-speed, cryocooling device for improved cryopreservation of small samples. - July 20, 2016 - MiTeGen, LLC
MiTeGen Announces Sentinel™, Real-Time Intensity Monitoring Beamstop System
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced the launch of their Sentinel™ Real-time Intensity Monitoring Beamstop Systems for X-ray beamlines. - July 15, 2016 - MiTeGen, LLC
AdvantaPure(R) Releases Its Schedule of Trade Show Appearances for Summer and Fall 2016; Includes Events in the US and Asia
AdvantaPure, the high-purity division of plastic tubing manufacturer NewAge Industries, will exhibit at shows in Taiwan, Massachusetts and China over the next several months. The shows will focus on biopharmaceutical and pharmaceutical equipment and processes. AdvantaPure will highlight its products that meet those processing needs, such as Single-Use tubing, process hose, leak-proof molded manifold assemblies, container closures, and wall pass-through systems. - July 15, 2016 - AdvantaPure
Trial Runners LLC is a “Great Place To Work®”
Trial Runners was certified as a great workplace today by the independent analysts at Great Place to Work®. Trial Runners earned this credential based on extensive ratings provided by its employees in anonymous surveys. - July 13, 2016 - Trial Runners
Quantgene Achieves Breakthrough in Liquid Biopsy Early Cancer Detection by Combining Machine Learning with Next-Generation PCR
Quantgene announced a breakthrough in early cancer detection with a new approach to detect tumor DNA in standard blood samples that combines proprietary machine learning algorithms with next-generation polymerase chain reaction (PCR) technology. The Quantgene researchers analyzed large sets of... - July 08, 2016 - Quantgene
MiTeGen Announces Expansion of Manufacturing and R&D Facilities
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced facility expansions which include space for manufacturing of a new line of automated high-speed cryocooling devices, as well as dedicated areas for the manufacturing of CrystalDirect™ crystallization plates. - June 29, 2016 - MiTeGen, LLC
Virun® Receives U.S. Patent 9,351,517 for Its Vitamin E, Esolv®, All-the-While Rebranding Itself as a Notable Formulation and Development Giant
Soon after international patent approval, Virun receives U.S. patent 9,351,571 for its principle technology, Esolv®. As research continues to show oils, fats and non-polar compounds have strong and growing efficacious health claims, the need to incorporate these compounds into foods, beverages and supplements will become even more sought-after. VIRUN’s extensive Portfolio, including Esolv®, is accelerating innovation. What Virun has created is notably notable in a noticeable way. - June 16, 2016 - VIRUN
AdvantaPure(R) Offers a New White Paper Focusing on Molded Tubing Connections; Illustrates the Risks and Expenses of Fluid Leaks in Biopharma Manufacturing Operations
Immediately available from high purity tubing manufacturer AdvantaPure is a report titled “How Molded Manifold Assemblies Prevent Leaks and Costly Consequences.” It addresses the risks and costs associated with tubing-to-fitting connection leaks and presents a solution, namely the use of molded connections. The white paper shows how critical leak risk becomes based on the number of connections in a manifold assembly. Additional white papers are available as well. - June 16, 2016 - AdvantaPure
ValueTrak 8.0 Release Re-Imagines Fee-for-Service Scorecarding with New Data Quality Metrics and Robust Customization Capabilities
ValueCentric, the industry leader in healthcare channel intelligence, announced enhancements to their Scorecard capabilities as part of ValueTrak 8.0 software release. Improvements include advanced Specialty and Channel Data Management metrics, integrating data completeness, timeliness, and... - June 15, 2016 - ValueCentric
South Korea Patent Allowance for Anti-Obesity Pet Vaccines to Braasch Biotech LLC
Braasch Biotech granted Anti-Obesity patent for pets by Korean Intellectual Property Office. Commercial utility and novelty for first therapeutic vaccine for use in obese dogs, cats and horses. - June 11, 2016 - Braasch Biotech LLC
Theater Slim PCR Cycler - Small Footprint, Small Price, Great Flexibility
MoBiTec is selling an incredibly small, light, and slim (4 cm), yet fully functional PCR instrument - The Theater Slim PCR Cycler. It is beneficial to small-sized labs and in-the-field research. - June 01, 2016 - MoBiTec GmbH
NuvOx Pharma Awarded STTR Grant from NCI for Ultrasound Contrast Agent to Diagnose Pancreatic Cancer
Evan Unger, MD, President and CEO of NuvOx Pharma, a Tucson based biotechnology company, announced that the company has been awarded a grant from the National Cancer Institute to develop an ultrasound contrast agent to diagnose pancreatic cancer. The Phase I Small Business Technology Transfer... - May 28, 2016 - NuvOx Therapeutics
MoBiTec GmbH Teams Up with TargetMol, US, to Offer Thousands of Inhibitors and Predetermined Screening Libraries
TargetMol supplies over 3000 compounds used in the study of cell signaling pathways and drug discovery. TargetMol provides more than 32 types of compound libraries, available for cell induction, signaling pathway, and high-throughput screening (HTS). - May 25, 2016 - MoBiTec GmbH
ValueCentric’s Training Conference, Focus 2016, Sells-Out in Record Time
ValueCentric, the leader in healthcare channel intelligence, today announced their annual user-training conference, being held in Princeton, NJ May 24th and 25th, has sold out. Anticipation for this event has accelerated with the company’s expanded data service offerings, a significant... - May 20, 2016 - ValueCentric
Now Available: A Red-Fluorescent cADDis Assay Kit, Manufactured by Montana Molecular, for Measuring cAMP Changes in Live Mammalian Cells
Cyclic AMP (cAMP) is the prototypical second messenger. The major receptor in eukaryotic cells, cAMP-dependent Protein Kinase (PKA), is ubiquitous. cAMP affects many different physiological and biochemical processes, including the activity of kinases. In contrast to the hitherto available green-fluorescent cADDis kit, the red-fluorescent counterpart can be used in combination with green-fluorescent gene constructs, such as GFP, or ion indicators. - May 19, 2016 - MoBiTec GmbH
National Brain Tumor Society Statement on Revised World Health Organization Classification of Tumors of the Central Nervous System
National Brain Tumor Society (NBTS), the largest nonprofit organization in the U.S. dedicated to the brain tumor community, today released the following statement from David F. Arons, Chief Executive Officer, on the publishing of the 2016 updated World Health Organization (WHO) Classification of... - May 12, 2016 - National Brain Tumor Society
Jivana Biotechnology Inc Adds Dr David Jablons to Its Advisory Committee
Dr David Jablons Brings Thoracic Surgical Oncology and Lung Cancer Drug Development Experience to The Jivana Advisory Committee. - May 06, 2016 - Jivana Biotechnology Inc
Pediatric Brain Tumor Foundation's New Campaign Aims to Raise Awareness in May and Every Day
The Pediatric Brain Tumor Foundation believes the conversation about brain tumors is bigger than just one month. That’s why the world's largest nonprofit funder of childhood brain tumor research is kicking off Brain Tumor Awareness Month with the “May and Every Day” campaign. - May 02, 2016 - Pediatric Brain Tumor Foundation
Pediatric Brain Tumor Foundation Introduces Free Toolkit for Newly Diagnosed Families
The Pediatric Brain Tumor Foundation is pleased to announce the publication of the Star Portfolio, a new resource for families of children recently diagnosed with a brain tumor. “Our new Star Portfolio is a toolkit designed to help families of newly diagnosed brain tumor patients partner... - April 28, 2016 - Pediatric Brain Tumor Foundation
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study - The Reanima Project - Is Death Reversible? - April 25, 2016 - Bioquark Inc.
ValueCentric’s Order Management Module Becomes Choice Solution for Top Pharma Manufacturers
ValueCentric, the industry leader in healthcare channel intelligence, announced today that their Order Management application surpassed a significant milestone of $200 billion in processed orders annually. Following two recent implementations, the company is now processing critical order data for... - April 22, 2016 - ValueCentric
Jivana Biotechnology Inc Announces Additions to Its Advisory Committee
Jivana Biotechnology adds Patrick Sage and Dr Frank Facchini to its advisory committee. - April 16, 2016 - Jivana Biotechnology Inc
Montana Molecular Appoints MoBiTec, Germany, as Distributor to Sell Genetically Encoded Fluorescent Biosensors
While fluorescent dye-based assays are powerful tools for high-throughput screening in engineered cell lines or cell lysates to show that signaling has occurred, genetically encoded sensors that measure dynamic processes in physiologically relevant cells provide a higher level of insight into how signals are regulated in both space and time. It is the regulation of signaling that controls cell function in both health and disease. - April 16, 2016 - MoBiTec GmbH
Arteric Appoints New Director of Technology Fast-Growing Pharmaceutical and Biotechnology Digital Agency Broadens Its Digital Healthcare Capabilities with 15-Year Veteran
Arteric is pleased to announce that Jon Fisher has joined Arteric as its new Director of Technology. Jon has worked in technology and digital marketing for 15 years and has spent the past 9 years working in a healthcare marketing agency. - April 15, 2016 - Arteric
The New York Center for Nanomedicine Research, Inc. is Signing a Strategic Agreement to Provide Drug Delivery Systems to ICAHRIS in Canada
Strategic agreement for the development of nanoparticules with application in Cancer, Type 2 diabetes and inflammation. The NYCNMR is providing to ICAHRIS, its innovative platform dedicated to Nanomedicine. The NY center is located in the upcoming Bio-Cluster located in Buffalo NY. - April 14, 2016 - New York Center for Nanomedicine Research, Inc.
BreviTest Awarded Grant from National Institute on Drug Abuse to Optimize Device for Rapid Cannabis Testing
BreviTest Technologies has been awarded a $234,412 grant from the National Institute on Drug Abuse of the National Institutes of Health (NIH) to explore rapid testing for THC, the main active ingredient in cannabis. The federal funds, awarded under the NIH’s Small Business Innovation Research... - April 14, 2016 - Cayman Chemical Company
Virun® at Ingredient Marketplace, Patent Grant in S. Korea, New Product Launches, Debut of Lightbulb Virun T-Shirts, and Webinar Controversy
VIRUN® plans on taking Orlando by storm at Ingredient Marketplace, where Virun’s Esolv® technology will take center stage, and Virun’s unique Omega smoothies and beverages will be available for sampling. South Korea granted Virun yet another patent protecting its unique technology. Virun launches new products and a new t-shirt. Virun’s latest webinar, “Inside Virun,” sparks controversy, and provides new business opportunities. - April 12, 2016 - VIRUN
Arteric Appoints New Group Account Supervisor; Fast-Growing Pharmaceutical and Biotechnology Digital Agency Strengthens Account Services
Arteric (http://arteric.com) is excited to introduce Heather Eckhaus as its new Group Account Supervisor. Heather joins Arteric from DigitasLBi in New York, where she led the Pitney Bowes account, with key initiatives including the global redesign and rebuild of pitneybowes.com as well as the... - April 11, 2016 - Arteric
ValueCentric Expands Specialty Data Quality and Performance Measurement Reporting Capabilities
Dashboards and reports are now available to Specialty manufacturer clients through the ValueTrak Platform. - April 07, 2016 - ValueCentric
Video Series Educates Families on Brain Tumors
In the Pediatric Brain Tumor Foundation’s new Family Support Learning Series videos, leading brain tumor experts discuss topics such as clinical trials, genetic susceptibility and molecular testing. - March 31, 2016 - Pediatric Brain Tumor Foundation
Global Medical Solutions to Sell China Operations to Yantai Dongcheng Biochemicals
Global Medical Solutions to sell China Operations to Yantai Dongcheng Biochemicals and enter into a long-term collaborative partnership in China. - March 28, 2016 - Global Medical Solutions
MiTeGen Announces Their In Situ-1 Crystallization Plates Have Been Selected for Use in Microgravity Crystallization Experiments Aboard the International Space Station
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced that a line of their products, the In Situ-1™ crystallization plates, will be used for research conducted on the International Space Station (ISS). - March 24, 2016 - MiTeGen, LLC